MariMed Inc.
MRMD · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $44 | $100 | $120 | $282 |
| - Cash | $7 | $15 | $10 | $30 |
| + Debt | $88 | $80 | $36 | $24 |
| Enterprise Value | $125 | $165 | $146 | $277 |
| Revenue | $158 | $149 | $134 | $121 |
| % Growth | 6.3% | 10.9% | 10.3% | – |
| Gross Profit | $63 | $66 | $64 | $66 |
| % Margin | 39.8% | 44.4% | 47.7% | 54.6% |
| EBITDA | $14 | $11 | $26 | $29 |
| % Margin | 8.8% | 7.5% | 19.3% | 23.8% |
| Net Income | -$12 | -$16 | $13 | $7 |
| % Margin | -7.7% | -10.8% | 10% | 5.9% |
| EPS Diluted | -0.032 | -0.044 | 0.035 | 0.019 |
| % Growth | 27.2% | -224.6% | 82.5% | – |
| Operating Cash Flow | $7 | $8 | $7 | $36 |
| Capital Expenditures | -$13 | -$20 | -$13 | -$19 |
| Free Cash Flow | -$6 | -$13 | -$5 | $17 |